Hepatotoxicity Related to Protein Kinase Inhibitors
Condition(s):CancerLast Updated:June 28, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):CancerLast Updated:June 28, 2022Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:December 10, 2021Unknown status
Condition(s):Kidney CancerLast Updated:January 18, 2020Recruiting
Condition(s):Cancer; High-grade GliomaLast Updated:October 8, 2020Unknown status
Condition(s):Non Small Cell Lung CarcinomaLast Updated:May 23, 2017Completed
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:November 8, 2013Completed
Condition(s):Breast CancerLast Updated:May 10, 2016Completed
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:August 1, 2019Completed
Condition(s):Hematological MalignanciesLast Updated:December 28, 2020Completed
Condition(s):Small Cell Lung CancerLast Updated:September 16, 2020Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.